An inactivated Ross River virus vaccine is well tolerated and immunogenic in an adult population in a randomized phase 3 trial

N. Wressnigg, M.V.W. Van Der Velden, D. Portsmouth, W. Draxler, M. O'Rourke, Peter Richmond, S. Hall, W.J.H. Mcbride, A.D. Redfern, J.G. Aaskov, P.N. Barrett, G. Aichingera

    Research output: Contribution to journalArticle

    19 Citations (Scopus)

    Fingerprint Dive into the research topics of 'An inactivated Ross River virus vaccine is well tolerated and immunogenic in an adult population in a randomized phase 3 trial'. Together they form a unique fingerprint.

    Medicine & Life Sciences

    Chemical Compounds